1. Home
  2. VYNE vs NCRA Comparison

VYNE vs NCRA Comparison

Compare VYNE & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$1.00

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYNE
NCRA
Founded
2003
2002
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
13.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VYNE
NCRA
Price
$0.41
$1.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
892.9K
31.7K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$524,000.00
$14,106,275.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.29
N/A
52 Week Low
$0.28
$0.70
52 Week High
$4.30
$2.40

Technical Indicators

Market Signals
Indicator
VYNE
NCRA
Relative Strength Index (RSI) 61.95 41.51
Support Level $0.37 $0.83
Resistance Level $0.39 $0.95
Average True Range (ATR) 0.03 0.08
MACD 0.00 0.01
Stochastic Oscillator 87.95 62.96

Price Performance

Historical Comparison
VYNE
NCRA

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: